BSX Investor Alert: Class Action Filed. Discover if you can recover losses.

NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) – Bronstein, Gewirtz & Grossman, LLC, an investor rights law firm with national recognition, has announced the initiation of a class action lawsuit. The legal action targets Boston Scientific Corporation (NYSE: BSX) along with certain of its executives. This lawsuit aims to secure financial compensation for investors who allegedly suffered losses due to violations of federal securities statutes. The suit encompasses all individuals and entities who purchased or otherwise obtained Boston Scientific shares during the period from July 23, 2025, through February 3, 2026, inclusive, designated as the "Class Period."

For investors tracking Boston Scientific (NYSE: BSX), our quantitative analysis shows the stock holds an RS Score of 51.96. This places it in the 10.20th percentile within its country and the 7.14th percentile within its sector. A deeper look into its components reveals Profitability as a strong area, scoring 80.40. However, other sections like Valuation (46.92), Growth (14.10), Momentum (8.38), and EPS Revisions (70.00) currently rank below the strong threshold. Want to discover which stocks rank the highest? Start your free 7-day trial at rankedstocks.com.